Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,275 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Fulvestrant and male breast cancer: a pooled analysis.
Zagouri F, Sergentanis TN, Chrysikos D, Dimopoulos MA, Psaltopoulou T. Zagouri F, et al. Among authors: dimopoulos ma. Breast Cancer Res Treat. 2015 Jan;149(1):269-75. doi: 10.1007/s10549-014-3240-z. Epub 2014 Dec 18. Breast Cancer Res Treat. 2015. PMID: 25519043
Expression of ARs in triple negative breast cancer tumors: a potential prognostic factor?
Giannos A, Filipits M, Zagouri F, Brandstetter A, Tsigginou A, Sotiropoulou M, Papaspyrou I, Sergentanis TN, Psaltopoulou T, Rodolakis A, Antsaklis A, Dimopoulos MA, Dimitrakakis C. Giannos A, et al. Among authors: dimopoulos ma. Onco Targets Ther. 2015 Jul 23;8:1843-7. doi: 10.2147/OTT.S78254. eCollection 2015. Onco Targets Ther. 2015. PMID: 26229492 Free PMC article.
Phase 2 study of ofatumumab, fludarabine and cyclophosphamide in relapsed/refractory Waldenström's macroglobulinemia.
Gavriatopoulou M, Kastritis E, Kyrtsonis MC, Vassilakopoulos TP, Roussou M, Fotiou D, Migkou M, Mpakiri M, Tasidou A, Terpos E, Dimopoulos MA. Gavriatopoulou M, et al. Among authors: dimopoulos ma. Leuk Lymphoma. 2017 Jun;58(6):1506-1508. doi: 10.1080/10428194.2016.1233541. Epub 2016 Oct 10. Leuk Lymphoma. 2017. PMID: 27724158 Clinical Trial. No abstract available.
The addition of IMiDs for patients with daratumumab-refractory multiple myeloma can overcome refractoriness to both agents.
Gavriatopoulou M, Kastritis E, Ntanasis-Stathopoulos I, Fotiou D, Roussou M, Migkou M, Ziogas DC, Kanellias N, Terpos E, Dimopoulos MA. Gavriatopoulou M, et al. Among authors: dimopoulos ma. Blood. 2018 Jan 25;131(4):464-467. doi: 10.1182/blood-2017-10-809293. Epub 2017 Nov 22. Blood. 2018. PMID: 29167176 Free article. No abstract available.
Rare manifestations of extramedullary myeloma: testicular plasmacytomas.
Ntanasis-Stathopoulos I, Gavriatopoulou M, Eleftherakis-Papaiakovou E, Kastritis E, Terpos E, Dimopoulos MA. Ntanasis-Stathopoulos I, et al. Among authors: dimopoulos ma. Leuk Lymphoma. 2018 Aug;59(8):2002-2004. doi: 10.1080/10428194.2017.1410887. Epub 2017 Dec 7. Leuk Lymphoma. 2018. PMID: 29214871 No abstract available.
Elevated vWF Antigen Serum Levels Are Associated With Poor Prognosis, and Decreased Circulating ADAMTS-13 Antigen Levels Are Associated With Increased IgM Levels and Features of WM but not Increased vWF Levels in Patients With Symptomatic WM.
Gavriatopoulou M, Terpos E, Ntanasis-Stathopoulos I, Papasotiriou I, Fotiou D, Migkou M, Roussou M, Kanellias N, Ziogas D, Dialoupi I, Eleutherakis Papaiakovou E, Kastritis E, Dimopoulos MA. Gavriatopoulou M, et al. Among authors: dimopoulos ma. Clin Lymphoma Myeloma Leuk. 2019 Jan;19(1):23-28. doi: 10.1016/j.clml.2018.07.294. Epub 2018 Aug 23. Clin Lymphoma Myeloma Leuk. 2019. PMID: 30224328
How I treat elderly patients with plasma cell dyscrasias.
Gavriatopoulou M, Fotiou D, Ntanasis-Stathopoulos I, Kastritis E, Terpos E, Dimopoulos MA. Gavriatopoulou M, et al. Among authors: dimopoulos ma. Aging (Albany NY). 2018 Dec 18;10(12):4248-4268. doi: 10.18632/aging.101707. Aging (Albany NY). 2018. PMID: 30568029 Free PMC article. Review.
1,275 results